John L Reagan (John Reagan)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Direct Oral Anticoagulants

Hodgkin Lymphoma

Multiple Myeloma

Top Venues

American journal of hematology

Leukemia & lymphoma

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Adel Chergui, John L Reagan
Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress. Cancers 15 (16) (2023)
Shadi Yaghi, Ian J Saldanha, Chelsea Misquith, Bashar Zaidat, Asghar Shah, Kareem Joudi, Bianca Persaud, Feras Abdul Khalek, Liqi Shu, Adam H de Havenon, Eva A Mistry, Ekaterina Bakradze, Eric D Goldstein, John L Reagan, Aikaterini Theodorou, Lina Palaiodimou, Karen L Furie, Thalia Shoshana Field, Georgios K Tsivgoulis, Brian Mac Grory
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke 53 (10) (2022)
Ari Pelcovits, Jozal Moore, Brianna Bakow, Rabin Niroula, Pamela Egan, John L Reagan
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (9) (2021)
Adam J Olszewski, James N Butera, John L Reagan, Jorge J Castillo
Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma. American journal of hematology 95 (4) (2020)
Mengyang Di, Orestis A Panagiotou, John L Reagan, Rabin Niroula, Adam J Olszewski
Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†. Leukemia & lymphoma 61 (14) (2020)
Colin A Vale, Pamela C Egan, Randall Ingham, Dimitrios Farmakiotis, John L Reagan
Antibiotic use during cytarabine consolidation in acute myeloid leukemia. Annals of hematology 100 (1) (2020)
Peter M Barth, Smith Giri, John L Reagan, Adam J Olszewski
Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma. American journal of hematology 96 (1) (2020)
Thomas A Ollila, John L Reagan, Adam J Olszewski
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base. Leukemia & lymphoma 60 (14) (2019)
Adam J Olszewski, Peter M Barth, John L Reagan
Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma. Cancer medicine 8 (16) (2019)
Adam J Olszewski, Thomas Ollila, John L Reagan
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas. British journal of haematology 181 (4) (2018)
Andrew E Foderaro, John L Reagan
Hodgkin lymphoma mimicking lung abscess. Blood 128 (25) (2018)
Jorge J Castillo, Thomas Guerrero-Garcia, Francesco Baldini, Emmanuelle Tchernonog, Guillaume Cartron, Slavisa Ninkovic, Kate Cwynarski, Daan Dierickx, Thomas Tousseyn, Frederick Lansigan, Yevgeny Linnik, Renzo Mogollon, Jose-Tomás Navarro, Adam J Olszewski, John L Reagan, Pasquale Fedele, Michael Gilbertson, George Grigoriadis, Michele Bibas
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. British journal of haematology 184 (4) (2018)
Anna Chorzalska, John Morgan, Nagib Ahsan, Diana O Treaba, Adam J Olszewski, Max Petersen, Nathan Kingston, Yan Cheng, Kara Lombardo, Christoph Schorl, Xiaoqing Yu, Roberta Zini, Annalisa Pacilli, Alexander Tepper, Jillian Coburn, Anita Hryniewicz-Jankowska, Ting C Zhao, Elena Oancea, John L Reagan, Olin D Liang, Leszek Kotula, Peter J Quesenberry, Philip A Gruppuso, Rossella Manfredini, Alessandro Maria Vannucchi, Patrycja M Dubielecka
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis. Blood 132 (19) (2018)
Anna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, Karim Roder, Xiaoqing Yu, John Morgan, Alexander Tepper, Steven Hines, Peng Zhang, Diana O Treaba, Ting C Zhao, Adam J Olszewski, John L Reagan, Olin D Liang, Philip A Gruppuso, Patrycja M Dubielecka
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia. Molecular oncology 12 (5) (2018)
Adam J Olszewski, John L Reagan, Jorge J Castillo
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas. American journal of hematology 93 (1) (2017)